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Abstract 
Short communication on DAPK2, with data on DNA 
and on the protein encoded. 
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Identity 
Other names: DRP1, DRP-1 
HGNC (Hugo): DAPK2 
Location: 15q22.31 
Location (base pair): Chromosome 15:63,907,036-
64,072,033 reverse strand. GRCh38:CM000677.2 
(Ensembl.org) 
DNA/RNA 
DAPK2 is a gene that codes for a protein that 
belongs to the serine/threonine protein kinase 
family. 
Transcription 
DPAK2 has 13 transcripts (3 coding), 75 orthologues 
and 11 paralogues (MYLK4, MYLK3, STK17A, 
DAPK3, DAPK1, OBSCN, SPEG, TTN, MYLK, 
STK17B, MYKL2) (ENSG00000035664). 
Blue highlighting indicates alternating exons; Red highlighting indicates amino acids encoded across a splice junction. 
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Schematic diagram of DAPK2 protein structure. The 42 KDa DAPK2 protein kinase bears three domain structures. A kinase 
domain on its N-terminal region determines specificity and allows for homodimerization through its basic loop. It is followed by a 
calcium/calmodulin (CaM)-regulated Serine/Threonine binding domain, which dictates kinase catalytic activity by unblocking 
substrate access when bound to Ca2+/CaM. Autophosphorylation of S308 decreases DAPK2 activity. The C-terminal 
dimerization domain allows for homodimerization. (Kawai T et al., 1999; Inbal B et al., 2000) 
 
Protein 
Description 
DAPK2 encodes a 42 KDa protein kinase (Inbal B., 
2000) that belongs to the serine/threonine protein 
family of five proapoptotic proteins with tumor 
suppressor activity. DAPK2 is soluble and cytosolic 
(Inbal B., 2000).  
It contains highly-conserved N-terminal kinase 
catalytic domain, followed by a conserved 
calcium/calmodulin regulatory binding domain and 
a C-terminal homodimerization domain 
encompassing the last 40 aminoacids, predicted to 
form two helices, which has no sequence homology 
to known protein sequences. 
Autophosphorylation restrains the apoptotic activity 
of DAPK2 kinase by controlling dimerization and 
calmodulin binding (Shani G et al., 2001). 
DAPK2 is a monomer in its activated state and a 
homodimer when inhibited by autophosphorylation 
at Ser-308 (Shani G et al., 2001). The dimers of 
DAPK2 are formed through the association of two 
opposed catalytic domains (Patel AK et al., 2001). 
DAPK2 is negatively regulated by the autoinhibitory 
CaM-binding domain and this inhibition is removed 
by the binding of Ca2+/CaM (Inbal B et al., 2000). 
That is, DAPK2 is activated by CaM in response to 
Ca2+ stimuli, and regulated by a double locking 
mechanism. DAPK2 is dephosphorylated at Ser-308 
in response to activated Fas and TNF-alpha 
receptors. 
UniProtKB: Q9UIK4 
Expression 
Widespread expression. Strong expression in heart, 
lung and skeletal muscle, but also expressed in 
colon, breast, spleen tissue and leukocytes (Kawai T 
et al., 1999; Inbal B et al., 2000).  
In mouse, DAPK2 is strongly and specifically 
expressed in interstitial cells of the kidney cortex 
(Guay JA et al., 2014). 
Localisation 
Cytoplasm (Inbal B et al., 2000), cytoplasmic 
vesicles, inside autophagic vesicles (Inbal B et al., 
2002). 
Function 
DAPK2 is a regulator of apoptosis, autophagy 
and inflammation (Geering B 2015). 
Apoptosis  
DAPK2 overexpression induces cell apoptosis in 50 
to 60% (Inbal B et al., 2000). Depletion of the C-
terminal tail of DAPK2 abolishes its apoptotic 
activity, while further truncation of the CaM-
regulatory domain strongly enhances its apoptotic 
effect (Inbal B et al., 2000). 
DAPK2 is a modulator of TRAIL signaling and 
TRAIL-induced apoptosis. Genetic ablation of 
DAPK2 causes phosphorylation of NF-KB and its 
transcriptional activity in several cancer cell lines, 
leading to the induction of several proapoptotic 
proteins (TNFRSF10A (DR4) and TNFRSF10B 
(DR5)) (Schlegel CR et al., 2014). 
Autophagy  
DAPK2 modulates MTOR activity by directly 
interacting and phosphorylating mTORC1. This way 
it suppresses mTOR activity to promote autophagy 
induction and autophagy levels under stress and 
steady-state conditions (Ber Y et al., 2015). 
Expression of DAPK2 in its activated form triggers 
autophagy in a caspase independent way. DAPK2 
mediates the formation of autophagic vesicles during 
apoptosis (Inbal B et al., 2002). Expression of 
dominant negative mutant of DAPK2 reduces 
autophagy (Inbal B et al., 2002). 
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Translation (370 aa) 
 
Protein serine/threonine kinase activity  
In vitro kinase assays, using myosin light chain 
(MLC) as substrate, have shown both MLC 
phosphorylation and DAPK2 autophosphorylation 
(Kawai T et al., 1999; Inbal B et al., 2000). DAPK2 
functions in vitro as a kinase that is capable of 
phosphorylating itself and an external substrate 
(Kawai T et al., 1999; Inbal B et al., 2000). 
Calmodulin binding  
The addition of Ca2+/CaM to in vitro kinase assays 
using myosin light chain (MLC) as substrate, lead to 
an increased amount of phosphorylated MLC, 
suggesting that DPK2 is regulated by binding to 
CaM (Kawai T et al., 1999; Inbal B et al., 2000). 
DPAK2 is negatively regulated by the autoinhibitory 
CaM-binding domain and this inhibition is removed 
by the binding of Ca2+/CaM (Inbal B et al., 2000). 
Truncation of the CaM-regulatory region of DAPK2 
enhances the apoptotic effect (Inbal B et al., 2000). 
Oxidative stress regulation  
DAPK2 regulates oxidative stress in cancer cells by 
preserving mitochondrial function. Depletion of 
DAPK2 leads to an increased production of 
mitochondrial superoxide anions and increased 
oxidative stress (Schlegel CR et al., 2015). 
Cellular metabolism 
DAPK2 kinase domain in important to maintain 
mitochondrial integrity and thus metabolism. 
Depletion of DPAK2 leads to metabolic alterations, 
decreased rate of oxidative phosphorylation and 
destabilized mitochondrial membrane potential 
(Schlegel CR et al., 2015). 
Membrane blebbing 
Interaction of DAPK2 with ACTA1 (α-actin-1) at 
the plasma membrane leads to massive membrane 
blebbing (Geering B et al., 2015). 
Expression of DAPK2 in its activated form triggers 
membrane blebbing and this process is caspase 
independent (Inbal B et al., 2002). Dominant 
negative mutants of DAPK2 reduce membrane 
blebbing during the p55/TRAF1 (TNF-receptor 1)-
induced apoptosis (Inbal B et al., 2002). 
Motility 
Interaction of DAPK2 with α-actin-1 leads to 
reduced cellular motility (Geering B et al., 2015). 
Intracellular signaling transduction 
Depletion of DAPK2 leads to the activation of 
classical stress-activated kinases, such as ERK,  
 
JNK and p38 (Schlegel CR et al., 2015). 
Positive regulation of eosinophil and neutrophil 
chemotaxis, and granulocyte maturation 
DPAK2 inhibition blocks recruitment of neutrophils 
to the site of inflammation in a peritonitis mouse 
model.  
DAPK2 functions in a signaling pathway that 
mediates motility in neutrophils and eosinophils in 
response to intermediary chemoattractants, but not to 
end-target chemoattractants (Geering B et al., 2014). 
DPAK2 regulates granulocytic motility by 
controlling cell spreading and polarization (Geering 
B et al., 2014) and may play a role in granulocyte 
maturation (Rizzi M et al., 2007). 
Regulation of erythropoiesis 
Among hematopoietic lineages, DPAK2 is 
expressed predominantly in erythroid cells. DPAK2 
is substantially up-modulated during late 
erythropoiesis (Fang J et al., 2008).  
In UT7epo cells, siRNA knock-down of DAPK2 
enhanced survival due to cytokine withdrawal, and 
DAPK2's phosphorylation and kinase activity also 
were erythropoietin (EPO)-modulated. DAPK2 
therefore comprises a new candidate attenuator of 
stress erythropoiesis (Fang J et al., 2008). 
The physiological substrate of DAPK2 is unknown 
although it is known to phosphorylate the myosin 
light chain in vitro (Inbal B et al., 2000). 
INTERACTION 
YWHAB (14-3-3-β) (Yuasa K et al., 2015) and α-
actinin-1 are novel DAPK2 binding partners 
(Geering B et al., 2015).  
The interaction of DAPK2 with α-actinin-1 is 
localized to the plasma membrane, resulting in 
massive membrane blebbing and reduced cellular 
motility, whereas the interaction of DAPK2 with 14-
3-3- β is localized to the cytoplasm, with no impact 
on blebbing, motility, or viability (Geering B et al 
2015). 14-3-3- proteins inhibit DAPK2 activity and 
its apoptotic effects (Yuasa K et al., 2015). 
DAPK2 also interacts with RAD1, MAPK1 and 
MLC1 (Steinmann S et al., 2015). 
Homology 
DAPK3/ZIPK/DLK (Death-related protein 1); 
STK17A (DRAK1/STK17B (DRAK2) (DAPK-
related apoptosis inducing protein kinases 1 and 2) 
(Shobat G et al., 2002) 
Mutations 
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Germinal 
No germline or somatic mutations have been 
described for DAPK2 gene. There are 4 structural 
variants are described for DPAK2 gene: nsv1567 
and nsv1569 leading to loss (PubMed ID 18451855), 
and nsv1568 and esv1414761 leading to insertions 
(PubMed IDs 18451855 and 17803354, 
respectively) (Database of Genomic Variants). 
Somatic 
Hypermethylation of the promoter region 
downregulates DAPK2 expression. 
Implicated in 
Hematological malignancies 
DAPK2 is a tumor suppressor gene. Promoter region 
hypermethylation is one mechanism of DAPK2 
inactivation in Hodgkin lymphoma-derived tumor 
cell lines (Tur MK et al., 2009).  
DAPK2 is up-regulated during normal myeloid 
differentiation and enhances neutrophil maturation 
in myeloid leukemic cells (Rizzi M et al., 2007).  
Acute promyelocytic leukemia (APL) patients have 
particularly low levels of DAPK2, where the 
predominant lesion causing its transcriptional 
repression isPML-RARA. and SPI1 (PU.1) bind to 
binding sites in the DAPK2 promoter. Restoring 
DAPK2 expression can rescue neutrophil 
differentiation (Humbert M. et al., 2014). 
Low DAPK2 expression is associated with CEBPA-
mutated AML patients and Humbert et al have found 
that DAPK2 is induced by the myeloid transcription 
factors PU.1 and CEBPA during granulocyte 
differentiation but repressed by PML-RARA in APL 
patients (Humbert M. et al., 2014).  
CEBPA-dependent regulation of DAPK2 during 
APL differentiation (Humbert M. et al., 2014). 
Breast cancer 
DAPK2 expression is regulated by MIR520H in 
breast cancer cells (Su CM. et al., 2016). 
Obesity 
DAPK2 regulates obesity-related attenuated 
autophagy in adipocytes – DAPK2 downregulation 
associates with attenuated adipocyte autophagic 
clearance in human obesity (Soussi H et al., 2015). 
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